Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ)
300122.SZ Stock Price Chart
Explore Chongqing Zhifei Biological Products Co., Ltd. interactive price chart. Choose custom timeframes to analyze 300122.SZ price movements and trends.
300122.SZ Company Profile
Discover essential business fundamentals and corporate details for Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
28 Sept 2010
Employees
7.22K
Website
https://www.zhifeishengwu.comCEO
Lingfeng Jiang
Description
Chongqing Zhifei Biological Products Co., Ltd. engages in the research, development, manufacture, and marketing of vaccines and biological products in China. The company was founded in 2009 and is based in Chongqing, China.
300122.SZ Financial Timeline
Browse a chronological timeline of Chongqing Zhifei Biological Products Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 18 Aug 2025
EPS came in at -¥0.12 falling short of the estimated ¥0.09 by -241.33%, while revenue for the quarter reached ¥2.54B , missing expectations by -30.80%.
Earnings released on 21 Apr 2025
EPS came in at -¥0.05 falling short of the estimated ¥0.09 by -155.56%, while revenue for the quarter reached ¥3.33B , missing expectations by -5.18%.
Earnings released on 31 Mar 2025
EPS came in at -¥0.13 , while revenue for the quarter reached ¥2.37B .
Dividend declared on 25 Dec 2024
A dividend of ¥0.20 per share was announced, adjusted to ¥0.20. The dividend was paid on 25 Dec 2024.
Earnings released on 25 Oct 2024
EPS came in at -¥0.04 falling short of the estimated ¥0.81 by -104.94%, while revenue for the quarter reached ¥4.53B , missing expectations by -50.69%.
Earnings released on 30 Aug 2024
EPS came in at ¥0.32 falling short of the estimated ¥0.76 by -57.89%, while revenue for the quarter reached ¥6.86B , missing expectations by -30.68%.
Dividend declared on 8 Aug 2024
A dividend of ¥0.80 per share was announced, adjusted to ¥0.80. The dividend was paid on 8 Aug 2024.
Earnings released on 23 Apr 2024
EPS came in at ¥0.61 falling short of the estimated ¥0.93 by -34.41%, while revenue for the quarter reached ¥11.35B , missing expectations by -11.54%.
Earnings released on 11 Mar 2024
EPS came in at ¥0.64 falling short of the estimated ¥0.86 by -25.58%, while revenue for the quarter reached ¥13.58B .
Earnings released on 26 Oct 2023
EPS came in at ¥0.95 surpassing the estimated ¥0.94 by +1.06%, while revenue for the quarter reached ¥14.83B , beating expectations by +14.72%.
Earnings released on 28 Aug 2023
EPS came in at ¥0.93 surpassing the estimated ¥0.79 by +17.72%, while revenue for the quarter reached ¥13.27B , beating expectations by +28.50%.
Dividend declared on 16 Jun 2023
A dividend of ¥0.50 per share was announced, adjusted to ¥0.50. The dividend was paid on 16 Jun 2023.
Stock split effective on 16 Jun 2023
Shares were split 77 : 50 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 19 Apr 2023
EPS came in at ¥1.27 surpassing the estimated ¥1.14 by +11.40%, while revenue for the quarter reached ¥11.17B , beating expectations by +19.50%.
Earnings released on 20 Mar 2023
EPS came in at ¥1.21 surpassing the estimated ¥1.17 by +3.42%, while revenue for the quarter reached ¥10.44B , beating expectations by +50.04%.
Earnings released on 27 Oct 2022
EPS came in at ¥1.17 falling short of the estimated ¥1.21 by -3.31%, while revenue for the quarter reached ¥9.47B , beating expectations by +21.79%.
Earnings released on 29 Aug 2022
EPS came in at ¥1.13 falling short of the estimated ¥1.36 by -16.91%, while revenue for the quarter reached ¥9.51B , beating expectations by +5.70%.
Dividend declared on 15 Jul 2022
A dividend of ¥0.60 per share was announced, adjusted to ¥0.39. The dividend was paid on 15 Jul 2022.
Earnings released on 28 Apr 2022
EPS came in at ¥1.20 falling short of the estimated ¥1.27 by -5.51%, while revenue for the quarter reached ¥8.84B , beating expectations by +24.41%.
Earnings released on 9 Feb 2022
EPS came in at ¥1.12 surpassing the estimated ¥0.53 by +111.32%, while revenue for the quarter reached ¥8.82B , beating expectations by +0.19%.
Earnings released on 28 Oct 2021
EPS came in at ¥1.82 surpassing the estimated ¥0.98 by +85.71%, while revenue for the quarter reached ¥8.66B .
Earnings released on 29 Aug 2021
EPS came in at ¥2.85 surpassing the estimated ¥1.18 by +141.53%, while revenue for the quarter reached ¥9.24B .
Dividend declared on 6 Aug 2021
A dividend of ¥0.50 per share was announced, adjusted to ¥0.32. The dividend was paid on 6 Aug 2021.
Earnings released on 20 Apr 2021
EPS came in at ¥0.59 , while revenue for the quarter reached ¥3.93B .
Earnings released on 21 Feb 2021
EPS came in at ¥0.51 surpassing the estimated ¥0.46 by +10.87%, while revenue for the quarter reached ¥4.14B .
Earnings released on 15 Oct 2020
EPS came in at ¥0.61 , while revenue for the quarter reached ¥4.06B .
300122.SZ Stock Performance
Access detailed 300122.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.